Quality Metrics Programs

CMS’s latest recalculation of Medicare Advantage Star Ratings—following litigation and affecting 2026/2027 bonus payment dynamics—underscores growing volatility in quality-based payment programs, with plans such as Humana, Clover Health, and broader MA stakeholders facing shifting revenue expectations tied to measurement methodology rather than care performance alone (CMS recalculates MA stars). At the provider level, the week’s VBC commentary points in the opposite direction: health systems and physician groups are investing in data infrastructure, EHR-enabled outreach, and care-management workflows to reduce quality reporting burden and make models like CJR-X and independent-practice VBC financially workable (TPMG value-based care approach). The common thread is that quality metrics remain central to VBC economics, but stakeholders are increasingly exposed to measurement instability, administrative complexity, and the need for stronger real-time performance infrastructure.